Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 366.81B | 401.63B | 339.76B | 323.75B | 336.24B |
Gross Profit | 44.11B | 40.79B | 33.72B | 43.77B | 39.76B |
EBITDA | 30.70B | 22.52B | 18.39B | 27.80B | 27.95B |
Net Income | 17.54B | 12.39B | 9.65B | 15.10B | 17.17B |
Balance Sheet | |||||
Total Assets | 592.05B | 579.62B | 513.62B | 477.61B | 472.44B |
Cash, Cash Equivalents and Short-Term Investments | 43.42B | 56.53B | 53.73B | 47.12B | 43.77B |
Total Debt | 194.21B | 186.15B | 169.41B | 160.04B | 115.04B |
Total Liabilities | 410.85B | 402.77B | 357.48B | 319.90B | 264.90B |
Stockholders Equity | 172.14B | 168.82B | 148.84B | 151.33B | 205.98B |
Cash Flow | |||||
Free Cash Flow | -18.17B | 17.30B | 8.70B | 11.41B | -14.98B |
Operating Cash Flow | 5.89B | 32.04B | 34.75B | 41.24B | 4.91B |
Investing Cash Flow | -36.21B | -41.82B | -27.45B | -22.53B | 5.30B |
Financing Cash Flow | 16.09B | 11.08B | -2.37B | -16.07B | -12.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥388.84B | 14.97 | 3.26% | 9.24% | 36.14% | ||
75 Outperform | ¥289.40B | 11.29 | 3.07% | 12.29% | 59.92% | ||
71 Outperform | ¥193.72B | 11.04 | 4.48% | -8.67% | 40.83% | ||
69 Neutral | ¥265.69B | 21.12 | 7.12% | 5.15% | 17.77% | -29.69% | |
58 Neutral | HK$14.28B | 4.69 | -3.01% | 5.60% | 3.67% | -54.16% | |
56 Neutral | $323.55B | ― | -0.17% | 6.25% | 3.06% | 94.98% |